Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Aescinate for Low Back Pain in Adults
NCT07339631Phase 1Recruiting
- Sponsor
- Xijing Hospital
- Start
- Mar 2026
- Primary completion
- Sep 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in chronic low back pain (CLBP) comparing Sodium Aescinate Tablets with Placebo (2 arms). Primary endpoint: Visual Analog Scale at 6 weeks. Started Mar 2026; status: recruiting.
02
Drugs
escin
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT07339631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07339631.